Immuno-Oncology Market Projected to Rake US$ 27,846.3 Mn by 2025
Owing to higher efficiency as compared to conventional therapies such as radiation, chemo and surgery, doctors around the globe are increasingly prescribing immunotherapy to cancer patients. Immuno-oncology therapies have low toxicity, making it easier for the patients to undergo such treatment procedures.
View full press release